SNGX 株価推移チャート
SNGX 株価予測
Soligenix Inc
$0.42
-70.25%
$-0.99
終値： Apr 28, 16:00:00 GMT-4
$0.4
-2.75%
$-0.01
プレマーケット： Apr 29, 05:54:37 GMT-4
戻る
Soligenix Inc (SNGX) 株価予測
主要データ
前終値
$1.41
始値
$0.6106
当日レンジ
$0.3701 - $0.6337
52週レンジ
$0.4093 - $6.23
取引高
14.9M
平均取引高
224.2K
配当利回り
--
1株当たり利益(TTM)
-2.76
時価総額
$4.2M
SNGXとは何ですか？
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. The company is headquartered in Princeton, New Jersey and currently employs 14 full-time employees. The Company’s segments include Specialized Biotherapeutics, and Public Health Solutions. Its Specialized BioTherapeutics business segment is engaged in developing and focused on the commercialization of HyBryte (a proposed name of SGX301), a novel photodynamic therapy (PDT), utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). Its Public Health Solutions segment includes development programs for RiVax, its ricin toxin vaccine candidate and SGX943, its therapeutic candidate for antibiotic-resistant and emerging infectious diseases and its vaccine programs targeting filoviruses (such as Marburg and Ebola) and CiVax, its vaccine candidate for the prevention of COVID-19 (caused by SARS-CoV-2).
